Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Capitalistaon Mar 15, 2023 10:05am
163 Views
Post# 35339502

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:ONCY Putting It's Best Foot Forward

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:ONCY Putting It's Best Foot ForwardHey Fox:  to my memory (and this is admittedly anecdotal) these fluff pieces come out usually just before an NR directly from ONC/Y.  They may be intended to get prospective investors to put ONC/Y on their watch list so when the more meaty NR comes out, the shareprice pop is more dramatic.

In any case - there was no effect from the most recent one.  That and the recent share price history suggests to me that investors are simply waiting for ONC/Y to make a business-related NR rather than the science-related ones they have put out for the past little while.  We know they have good (even great) science - the market just wants to see them monetize it.  In the immortal words of Rod Tidwell in "Jerry Maguire":  "Show me the money!"
<< Previous
Bullboard Posts
Next >>